ZLD 4.29% 67.0¢ zelira therapeutics limited

Non-commercial prices for "research" being paid to closely related parties, page-9

  1. 755 Posts.
    lightbulb Created with Sketch. 186
    I think you are confusing two different things:

    Recruitment fee of 8 patients (ZLD is paying Emerald $99,920 - (available at Cannabis Access or Cannvalate for under 1/10th this price)

    or

    Clinical Research Costs for a whole clinical trial

    If you read the text, it says very clearly that ZLD is responsible for getting their own Ethics approvals (HREC) done.

    There are some serious questions about why ZLD is shelling money out to related entities like this.


    Big question marks now:

    1. Non-novel drugs
    2. Underpowered clinical trials
    3. No CTN numbers for any trials
    4. Excessive fees paid to related parties
    5. No dossiers collected by any regulatory bodies

    Its looking more and more concerning.


 
watchlist Created with Sketch. Add ZLD (ASX) to my watchlist
(20min delay)
Last
67.0¢
Change
-0.030(4.29%)
Mkt cap ! $7.602M
Open High Low Value Volume
70.0¢ 70.0¢ 67.0¢ $1.548K 2.246K

Buyers (Bids)

No. Vol. Price($)
2 4350 67.0¢
 

Sellers (Offers)

Price($) Vol. No.
72.0¢ 229 1
View Market Depth
Last trade - 15.45pm 13/09/2024 (20 minute delay) ?
ZLD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.